-
11.Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands 有权
标题翻译: 取代的3-磺基吲唑衍生物作为5-羟色胺-6配体公开(公告)号:US20070037802A1
公开(公告)日:2007-02-15
申请号:US11504350
申请日:2006-08-14
申请人: Hassan Elokdah , Alexander Greenfield , Kevin Liu , Robert McDevitt , Geraldine McFarlane , Cristina Grosanu , Jennifer Lo , Yanfang Li , Albert Robichaud , Ronald Bernotas
发明人: Hassan Elokdah , Alexander Greenfield , Kevin Liu , Robert McDevitt , Geraldine McFarlane , Cristina Grosanu , Jennifer Lo , Yanfang Li , Albert Robichaud , Ronald Bernotas
IPC分类号: A61K31/5377 , A61K31/496 , A61K31/454 , A61K31/416 , C07D413/02 , C07D403/02 , C07D231/56
CPC分类号: C07D231/56 , C07D401/12 , C07D403/06 , C07D403/12 , C07D413/12
摘要: The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.
摘要翻译: 本发明提供式I化合物及其用于治疗与5-HT 6受体相关或受其影响的中枢神经系统疾病的用途。